ALTIMMUNE, INC. (ALT) Current Ratio
- Current ratio · latest quarter: Value 26.78×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 26.78× | Current assets / current liabilities. $334.81M ÷ $12.50M ≈ 26.78× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 334.81M USD | Assets, Current |
| Current obligations | 12.50M USD | Liabilities, Current |
| Cash and equivalents | 63.01M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 263.27M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 1.27M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $334.81M | $12.50M | $63.01M | $263.27M | (m) | (m) | $1.27M | (m) | 26.78× |
| 2026-03-31 | $334.68M | $11.32M | $97.60M | (m) | (m) | (m) | $1.53M | (m) | 29.56× |
| 2025-12-31 | $278.19M | $15.00M | $43.76M | $229.70M | (m) | (m) | $2.72M | (m) | 18.55× |
| 2025-09-30 | $216.62M | $12.61M | $61.24M | (m) | (m) | (m) | $4.80M | (m) | 17.18× |
| 2025-06-30 | $188.42M | $9.22M | $183.10M | (m) | (m) | (m) | $851.00K | (m) | 20.44× |
| 2025-03-31 | $155.26M | $9.80M | $49.10M | (m) | (m) | (m) | $1.08M | (m) | 15.85× |
| 2024-12-31 | $137.25M | $10.47M | $36.93M | (m) | (m) | (m) | $211.00K | (m) | 13.11× |
| 2024-09-30 | $145.76M | $8.64M | $31.47M | (m) | (m) | (m) | $1.13M | (m) | 16.87× |
| 2024-06-30 | $171.19M | $15.15M | $57.13M | (m) | (m) | (m) | $2.69M | (m) | 11.30× |
| 2024-03-31 | $187.51M | $11.33M | $78.98M | (m) | (m) | (m) | $3.76M | (m) | 16.55× |
| 2023-12-31 | $209.63M | $12.14M | $135.12M | (m) | (m) | (m) | $2.07M | (m) | 17.26× |
| 2023-09-30 | $152.96M | $11.87M | $86.86M | (m) | (m) | (m) | $3.05M | (m) | 12.89× |
| 2023-06-30 | $169.53M | $11.44M | $102.35M | (m) | (m) | (m) | $4.04M | (m) | 14.82× |
| 2023-03-31 | $173.11M | $14.95M | $104.69M | (m) | (m) | (m) | $5.24M | (m) | 11.58× |
| 2022-12-31 | $192.81M | $17.05M | $111.10M | (m) | (m) | (m) | $4.80M | (m) | 11.31× |
| 2022-09-30 | $211.00M | $15.74M | $127.47M | (m) | (m) | (m) | $1.42M | (m) | 13.40× |
| 2022-06-30 | $195.50M | $13.85M | $135.86M | (m) | (m) | (m) | $2.87M | (m) | 14.12× |
| 2022-03-31 | $191.09M | $19.12M | $179.95M | (m) | (m) | (m) | $2.21M | (m) | 9.99× |
| 2021-12-31 | $204.13M | $18.28M | $190.30M | (m) | (m) | (m) | $2.03M | (m) | 11.17× |
| 2021-09-30 | $218.26M | $19.13M | $174.86M | (m) | (m) | (m) | $6.08K | (m) | 11.41× |
| 2021-06-30 | $238.62M | $9.10M | $174.10M | (m) | (m) | (m) | $1.42M | (m) | 26.23× |
| 2021-03-31 | $245.19M | $9.82M | $149.93M | (m) | (m) | (m) | $418.24K | (m) | 24.96× |
| 2020-12-31 | $230.26M | $12.02M | $115.92M | (m) | (m) | (m) | $612.29K | (m) | 19.16× |
| 2020-09-30 | $218.13M | $6.29M | $143.50M | (m) | (m) | (m) | $874.88K | (m) | 34.66× |
| 2020-06-30 | $87.97M | $4.92M | $64.74M | (m) | (m) | (m) | $195.22K | (m) | 17.89× |
| 2020-03-31 | $39.64M | $6.05M | $11.28M | (m) | (m) | (m) | $929.63K | (m) | 6.56× |
| 2019-12-31 | $39.39M | $3.92M | $8.96M | (m) | (m) | (m) | $18.23K | (m) | 10.04× |
| 2019-09-30 | $41.62M | $2.47M | $10.97M | (m) | (m) | (m) | $49.88K | (m) | 16.87× |
| 2019-06-30 | $46.11M | $3.48M | $41.67M | (m) | (m) | (m) | $270.10K | (m) | 13.25× |
| 2019-03-31 | $49.41M | $3.68M | $44.30M | (m) | (m) | (m) | $14.75K | (m) | 13.44× |
| 2018-12-31 | $39.37M | $4.53M | $33.72M | (m) | (m) | (m) | $372.86K | (m) | 8.70× |
| 2018-09-30 | $11.97M | $8.34M | $7.96M | (m) | (m) | (m) | $150.74K | (m) | 1.43× |
| 2018-06-30 | $11.87M | $7.07M | $4.17M | (m) | (m) | (m) | $245.25K | (m) | 1.68× |
| 2018-03-31 | $19.92M | $5.16M | $4.56M | (m) | (m) | (m) | $513.17K | (m) | 3.86× |
| 2017-12-31 | $23.47M | $3.84M | $8.77M | (m) | (m) | (m) | $129.07K | (m) | 6.11× |
| 2017-09-30 | $26.12M | $4.18M | $17.12M | (m) | (m) | (m) | $495.06K | (m) | 6.25× |
| 2017-06-30 | $17.00M | $5.53M | $8.37M | (m) | (m) | (m) | $1.13M | (m) | 3.07× |
| 2017-03-31 | $18.29M | $2.23M | $15.78M | (m) | $1.00M | (m) | $839.47K | (m) | 8.19× |
| 2016-12-31 | $4.49M | $5.47M | $2.88M | (m) | (m) | (m) | $2.01M | (m) | 0.82× |
| 2016-09-30 | $138.04M | $3.73M | $69.11M | (m) | (m) | (m) | $614.54K | (m) | 37.02× |
| 2016-06-30 | $25.40M | $3.27M | $23.16M | (m) | (m) | (m) | $711.11K | (m) | 7.77× |
| 2016-03-31 | $16.14M | $2.64M | $14.24M | (m) | (m) | (m) | $166.36K | (m) | 6.11× |
| 2015-12-31 | $17.23M | $2.18M | $15.57M | (m) | (m) | (m) | $521.12K | (m) | 7.90× |
| 2015-09-30 | $18.25M | $2.38M | $17.39M | (m) | (m) | (m) | $306.17K | (m) | 7.66× |
| 2015-06-30 | $19.91M | $3.34M | $18.41M | (m) | (m) | (m) | $208.46K | $249.49K | 5.97× |
| 2015-03-31 | $22.74M | $4.54M | $15.72M | (m) | (m) | (m) | $536.99K | $498.20K | 5.01× |
| 2014-12-31 | $19.25M | $2.58M | $18.64M | (m) | (m) | (m) | $391.40K | $746.15K | 7.46× |
| 2014-09-30 | $20.59M | $3.88M | $19.62M | (m) | (m) | (m) | $282.02K | $993.32K | 5.30× |
| 2014-06-30 | $12.43M | $2.83M | $11.27M | (m) | (m) | (m) | $437.38K | $1000.00K | 4.39× |
| 2014-03-31 | $11.59M | $3.47M | $9.53M | (m) | (m) | (m) | $471.80K | $1000.00K | 3.34× |
| 2013-12-31 | $14.34M | $6.80M | $10.48M | (m) | (m) | (m) | $1.13M | $1000.00K | 2.11× |
| 2013-09-30 | $17.77M | $5.41M | $15.94M | (m) | (m) | (m) | $1.16M | $1000.00K | 3.28× |
| 2013-06-30 | $21.69M | $7.72M | $15.79M | (m) | (m) | (m) | $2.99M | $1000.00K | 2.81× |
| 2013-03-31 | $19.07M | $7.79M | $12.87M | (m) | (m) | (m) | $1.29M | $1000.00K | 2.45× |
| 2012-12-31 | $19.80M | $7.49M | $12.70M | (m) | (m) | (m) | $1.70M | $750.00K | 2.64× |
| 2012-09-30 | $20.38M | $6.97M | $14.73M | (m) | (m) | (m) | $1.85M | $681.82K | 2.92× |
| 2012-06-30 | $20.68M | $5.66M | $11.78M | (m) | (m) | (m) | $2.06M | $454.55K | 3.65× |
| 2012-03-31 | $21.53M | $5.31M | $15.30M | (m) | (m) | (m) | $1.41M | $195.41K | 4.05× |
| 2011-12-31 | $19.61M | $4.62M | $11.24M | (m) | (m) | (m) | $1.45M | (m) | 4.25× |
| 2011-09-30 | $18.34M | $3.69M | $10.41M | (m) | $4.04M | (m) | $445.51K | (m) | 4.97× |
| 2011-06-30 | $22.94M | $5.93M | $14.16M | (m) | $4.38M | (m) | $2.48M | (m) | 3.87× |
| 2010-12-31 | $23.58M | $6.16M | $11.79M | (m) | $5.37M | (m) | $3.13M | (m) | 3.83× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |